Meet The Team

Maria Dominguez

Maria Dominguez joins ApconiX as Head of DMPK, bringing 20+ years of drug metabolism and pharmacokinetics expertise. Maria will work with Dr Richard Knight to develop ApconiX’s DMPK capabilities, helping clients optimize compounds for clinical development. Her career spans over pharmaceutical companies like Janssen, Merck and Almirall and biotechs such as Exscientia (now Recursion), and progressed from bioanalyst to Vice President of Preclinical Development, building and leading multidisciplinary teams across the UK and US. At Janssen, she managed DMPK strategy for 20+ discovery projects across infectious disease, immunology, neuroscience, and oncology. She values company culture and collaborative consultancy experiences that benefit employees, clients, and the organisation alike.